[IMJ On-Air] Hyperglycaemia and COVID-19 episode artwork

EPISODE · Jan 16, 2023 · 35 MIN

[IMJ On-Air] Hyperglycaemia and COVID-19

from Pomegranate Health

In the first year of the COVID-19 pandemic, a handful of international studies showed that there was increased risk of adverse outcomes in hospitalised patients comorbid for diabetes. Odds ratios for mortality conferred by pre-existing diabetes ranged from 1.5 to 3.6. What this relationship might be in Australia was not known until researchers in Melbourne retrospectively examined electronic medical records from the two waves of COVID-19 in that city.  The prevalence of diabetes among Melbourne inpatients is around 35% and in 2020 over 70% of all Australia’s case load was in Victoria. This presented an opportunity to observe the relationship between the conditions with substantial statistical power. But while ICU admission and mortality were more common in those with diabetes than those without, neither diabetes nor hyperglycaemia were independently associated with in-hospital mortality. In this podcast the authors speculate as to why there was this deviation from patterns observed internationally. A possible explanation involves the receipt of dexamethasone therapy in patients with hyperglycaemia, which was found by other researchers to be preventative for COVID-19-associated mortality. GuestsAssociate Professor John Wentworth FRACP (Royal Melbourne Hospital, Walter and Eliza Hall Institute) Dr Rahul Barmanray FRACP (Royal Melbourne Hospital; the University of Melbourne)Dr Dev Kevat FRACP (Western Health; Monash University)Dr Mohammad Ashraful Islam (Goulburn Valley Health) Key ReferenceRahul D Barmanray Diabetes IN hospital – Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinationsInternal Medicine Journal 2021; 53(1)Access to IMJ, JPCH and OMJ for RACP membersPlease visit the Pomegranate Health web page for a transcript and supporting references. Login to MyCPD to record prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health’ in Apple Podcasts, Spotify, Castbox, or any podcasting app.

Episode metadata supplied by the publisher feed · Published Jan 16, 2023

Embed this episode

In the first year of the COVID-19 pandemic, a handful of international studies showed that there was increased risk of adverse outcomes in hospitalised patients comorbid for diabetes. Odds ratios for mortality conferred by pre-existing diabetes ranged from 1.5 to 3.6. What this relationship might be in Australia was not known until researchers in Melbourne retrospectively examined electronic medical records from the two waves of COVID-19 in that city. The prevalence of diabetes among M...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

[IMJ On-Air] Hyperglycaemia and COVID-19

0:00 35:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Pomegranate Health?

This episode is 35 minutes long.

When was this Pomegranate Health episode published?

This episode was published on January 16, 2023.

Can I download this Pomegranate Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!